RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
 USA
 World Healthcare
 
   Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
  AIDS
  Anthrax
  Dengue
  Ebola
  HCV
  Influenza
  Leishmaniasis
  Malaria
  MRSA
  Mumps
  Pertussis
  Prion Diseases
  SARS
  Shigella
  Small Pox
  Tuberculosis
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Oct 11, 2012 - 10:22:56 PM
Infectious Diseases Channel

subscribe to Infectious Diseases newsletter
Latest Research : Infectious Diseases

   EMAIL   |   PRINT
Study finds herpes virus in 98% of healthy participants

Jan 5, 2005 - 4:58:00 AM

 
[RxPG] A study led by Dr. Herbert Kaufman, Boyd Professor of Ophthalmology at Louisiana State University Health Sciences Center in New Orleans, published in the January issue of Investigative Ophthalmology & Visual Science, found that 98% of the participants who are healthy individuals with no evidence of any symptoms did in fact shed herpes simplex virus type I (HSV-1) DNA in their tears and saliva at least once during the course of the 30-day study. The study was undertaken to assess the frequency of shedding of HSV-1 DNA in tears and saliva of asymptomatic individuals.

While not the first, the researchers report that this study uses the most sensitive techniques in a cross-sectional assessment performed to date of the presence of HSV-1 DNA in the eyes and mouths of healthy individuals, in terms of population size and total samples collected.

HSV-1, and to a lesser extent, HSV-2 are known to be the leading causes of virus-induced blindness in the Western world, with approximately 500,000 individuals having herpetic eye disease in the United States. Humans are reservoirs for herpes viruses and shedding in infected individuals when they are asymptomatic is a major factor in the transmission of the virus.

The 50 participants, who were recruited from the general population, ranged in age from 19 to 71. Nineteen were male and 31 female. African-Americans comprised 78% of the participants. The participants were asked to provide a blood sample as well as samples from twice daily swabs of their eyes and mouths for 30 consecutive days. Samples were analyzed using methods including real-time PCR, the gold standard for HSV detection in clinical samples.

Shedding was intermittent, but overall, 49 participants (98%) shed HSV-1 DNA at least once during the study. Thirty-seven participants (74%) had positive blood test results. The percentages of positive results between the eye and mouth swabs were approximately equivalent, but one measure showed higher volume in saliva than in tears. Only one participant did not shed any HSV-1 DNA. Three participants shed HSV-1 DNA in their tears but not their saliva and two had only positive saliva swabs.

Population demographics play a fundamental role in the prevalence of HSV infections. Other documented significant predictors include age, stress, socioeconomic status, level of education, age of first intercourse and total years of sexual activity. Several studies have noted an increase in herpetic disease with increased age. This could be a result of repeated infection and/or reactivation of the primary HSV infection. Also, natural stress factors such as sunlight exposure may have been a contributing factor to HSV-1 DNA shedding. UV exposure is a known trigger to activate latent HSV.

"The fact that HSV-1 DNA was discovered in such a high percentage of healthy people in the general population tells us that the virus is everywhere and it's unavoidable," said Dr. Kaufman, who developed the first effective antiviral drug for herpes infections of the eye.

In addition to Dr. Kaufman, the research team included Drs. James Hill, Hilary Thompson, Gregory Sloop, as well as Emily Varnell and Ann Azcuy. They concluded that control of virus excretion could well limit transmission, especially of more virulent strains of virus. More important, if such a high proportion of adults excrete virus, the reduction and/or prevention of virus excretion may be a simple, cost-effective way to evaluate new antiviral drugs.



Publication: published in the January issue of Investigative Ophthalmology & Visual Science
On the web: Louisiana State University Health Science Center  

Advertise in this space for $10 per month. Contact us today.


Related Infectious Diseases News
4 UCLA stem cell researchers receive CIRM Early Translational grants
Professor Vanessa Hayes awarded for exceptional Africa-related work
Plant-based compound may inhibit HIV
Innovative intervention program improves life for rural women in India living with HIV/AIDS
The American Society for Microbiology honors Baligh Yehia
Thomas J. Coates receives 2013 Elizabeth Fries Health Education Award
Scientists find ethnicity linked to antibodies
2013 Canada Gairdner Global Health Award goes to King Holmes for STD work
Study identifies ways to increase HIV testing, reduce HIV infection
A device to speed up HIV diagnostic test

Subscribe to Infectious Diseases Newsletter

Enter your email address:


 Additional information about the news article
The research was supported in part by a grant by the National Eye Institute and by a Senior Scientific Investigator award from Research to Prevent Blindness, Inc.
 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
Contact us

RxPG Online

Nerve

 

    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)